Pubblicazioni

Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications

2023 - EXPERT REVIEW OF CLINICAL PHARMACOLOGY

Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Ortega-Paz, Luis; D'Amario, Domenico; De Caterina, Raffaele; Mehran, Roxana; Michael Gibson, C; Angiolillo, Dominick J.

Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin. A pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy

2022 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY

Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Been, Latonya; Abou Jaoude, Patrick; Rivas, Andrea; Zhou, Xuan; Jia, Sida; Maaliki, Naji; Hoon Lee, Chang; M Pineda, Andres; Suryadevara, Siva; Soffer, Daniel; M Zenni, Martin; Geisler, Tobias; K Jennings, Lisa; A Bass, Theodore; J Angiolillo, Dominick